PDB Short entry for 3E88 HEADER TRANSFERASE 19-AUG-08 3E88 TITLE CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- TITLE 2 COMPETITIVE INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAC-BETA SERINE/THREONINE-PROTEIN KINASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: AKT2 KINASE DOMAIN (146-480); COMPND 5 SYNONYM: RAC-PK-BETA, PROTEIN KINASE AKT-2, PROTEIN KINASE B, BETA, COMPND 6 PKB BETA; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA PEPTIDE; COMPND 12 CHAIN: C, D; COMPND 13 SYNONYM: GSK-3 BETA; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKT2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. IT IS FOUND SOURCE 12 NATURALLY IN HUMAN. KEYWDS AKT2, KINASE, GSK3 BETA, ATP-BINDING, NUCLEOTIDE-BINDING, KEYWDS 2 PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT KEYWDS 3 SIGNALING PATHWAY EXPDTA X-RAY DIFFRACTION AUTHOR N.O.CONCHA,P.A.ELKINS,A.SMALLWOOD,P.WARD REVDAT 7 20-OCT-21 3E88 1 REMARK SEQADV LINK REVDAT 6 25-OCT-17 3E88 1 REMARK REVDAT 5 13-JUL-11 3E88 1 VERSN REVDAT 4 20-APR-11 3E88 1 HET REVDAT 3 17-MAR-09 3E88 1 JRNL REVDAT 2 24-FEB-09 3E88 1 VERSN REVDAT 1 14-OCT-08 3E88 0 JRNL AUTH M.B.ROUSE,M.A.SEEFELD,J.D.LEBER,K.C.MCNULTY,L.SUN, JRNL AUTH 2 W.H.MILLER,S.ZHANG,E.A.MINTHORN,N.O.CONCHA,A.E.CHOUDHRY, JRNL AUTH 3 M.D.SCHABER,D.A.HEERDING JRNL TITL AMINOFURAZANS AS POTENT INHIBITORS OF AKT KINASE JRNL REF BIOORG.MED.CHEM.LETT. V. 19 1508 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19179070 JRNL DOI 10.1016/J.BMCL.2009.01.002 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.A.SEEFELD,M.B.ROUSE,K.C.MCNULTY,L.SUN,J.WANG, REMARK 1 AUTH 2 D.S.YAMASHITA,A.CHOUDHRY,M.D.SCHABER,R.KUMAR,J.KAHANA, REMARK 1 AUTH 3 S.Y.ZHANG,E.A.MINTHORN,K.K.KORETKE,N.O.CONCHA,D.A.HEERDING REMARK 1 TITL DISCOVERY OF 5-PYRROLOPYRIDINYL-2-THIOPHENECARBOXAMIDES AS REMARK 1 TITL 2 POTENT AKT KINASE INHIBITORS REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 22560 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1219 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.57 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1615 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.31 REMARK 3 BIN R VALUE (WORKING SET) : 0.3530 REMARK 3 BIN FREE R VALUE SET COUNT : 100 REMARK 3 BIN FREE R VALUE : 0.4030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5426 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 62 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.04000 REMARK 3 B22 (A**2) : 0.04000 REMARK 3 B33 (A**2) : -0.06000 REMARK 3 B12 (A**2) : 0.02000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 2.378 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.345 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.257 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 24.405 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.915 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.887 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5622 ; 0.005 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3934 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7588 ; 1.170 ; 1.984 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9488 ; 0.764 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 656 ; 5.181 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 274 ;32.952 ;22.993 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 990 ;13.591 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 48 ;13.151 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 806 ; 0.052 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6136 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1236 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1140 ; 0.180 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3995 ; 0.172 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2702 ; 0.176 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2836 ; 0.079 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 140 ; 0.113 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 16 ; 0.120 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 83 ; 0.204 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 7 ; 0.043 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4291 ; 0.521 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1336 ; 0.073 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5312 ; 0.555 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2905 ; 0.391 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2276 ; 0.601 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 146 A 480 2 REMARK 3 1 B 146 B 480 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 1893 ; 0.01 ; 0.05 REMARK 3 MEDIUM POSITIONAL 1 A (A): 2630 ; 0.17 ; 0.50 REMARK 3 TIGHT THERMAL 1 A (A**2): 1893 ; 0.01 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 2630 ; 0.06 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : C D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 C 3 C 12 4 REMARK 3 1 D 3 D 12 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 2 C (A): 141 ; 0.26 ; 0.50 REMARK 3 MEDIUM THERMAL 2 C (A**2): 141 ; 0.06 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 146 A 480 REMARK 3 RESIDUE RANGE : C 3 C 12 REMARK 3 ORIGIN FOR THE GROUP (A): -15.7570 48.3830 -3.7660 REMARK 3 T TENSOR REMARK 3 T11: 0.0054 T22: -0.0311 REMARK 3 T33: -0.0029 T12: 0.0100 REMARK 3 T13: -0.0102 T23: -0.0212 REMARK 3 L TENSOR REMARK 3 L11: 1.0030 L22: 0.8819 REMARK 3 L33: 0.8569 L12: -0.6202 REMARK 3 L13: 0.1480 L23: 0.1383 REMARK 3 S TENSOR REMARK 3 S11: 0.0298 S12: -0.0285 S13: -0.0392 REMARK 3 S21: -0.0389 S22: -0.0311 S23: 0.0456 REMARK 3 S31: -0.0648 S32: -0.0615 S33: 0.0013 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 146 B 480 REMARK 3 RESIDUE RANGE : D 3 D 12 REMARK 3 ORIGIN FOR THE GROUP (A): -24.4190 4.0920 3.7440 REMARK 3 T TENSOR REMARK 3 T11: -0.0031 T22: -0.0114 REMARK 3 T33: -0.0101 T12: -0.0235 REMARK 3 T13: -0.0165 T23: -0.0023 REMARK 3 L TENSOR REMARK 3 L11: 0.3970 L22: 1.3131 REMARK 3 L33: 0.8072 L12: 0.2521 REMARK 3 L13: 0.1708 L23: -0.0637 REMARK 3 S TENSOR REMARK 3 S11: -0.0430 S12: -0.0150 S13: 0.0370 REMARK 3 S21: -0.0182 S22: 0.0371 S23: 0.0634 REMARK 3 S31: -0.0812 S32: 0.0056 S33: 0.0060 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3E88 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-AUG-08. REMARK 100 THE DEPOSITION ID IS D_1000048998. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : UN-FOCUSED BEAM REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23801 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 41.210 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.17900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : 0.67000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% PEG 2KMME, 100 MM TRIS PH 8.0 AND REMARK 280 10% ETHANOL DIFFUSED IN. SEEDED., VAPOR DIFFUSION, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.07667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 15.03833 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 452 REMARK 465 PRO A 453 REMARK 465 ASP A 454 REMARK 465 ARG A 455 REMARK 465 TYR A 456 REMARK 465 ASP A 457 REMARK 465 SER A 458 REMARK 465 LEU A 459 REMARK 465 GLY A 460 REMARK 465 LEU A 461 REMARK 465 LEU A 462 REMARK 465 GLU A 463 REMARK 465 LEU A 464 REMARK 465 ASP A 465 REMARK 465 PRO B 452 REMARK 465 PRO B 453 REMARK 465 ASP B 454 REMARK 465 ARG B 455 REMARK 465 TYR B 456 REMARK 465 ASP B 457 REMARK 465 SER B 458 REMARK 465 LEU B 459 REMARK 465 GLY B 460 REMARK 465 LEU B 461 REMARK 465 LEU B 462 REMARK 465 GLU B 463 REMARK 465 LEU B 464 REMARK 465 ASP B 465 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 245 -52.06 79.31 REMARK 500 ARG A 274 -2.73 67.98 REMARK 500 ASP A 293 93.97 61.99 REMARK 500 ASP A 303 -115.68 21.49 REMARK 500 ASN A 325 -156.35 66.18 REMARK 500 LEU A 385 32.71 -96.53 REMARK 500 ASP A 399 -112.67 55.44 REMARK 500 GLN A 429 48.91 -89.03 REMARK 500 GLN A 472 55.93 -144.18 REMARK 500 PHE A 473 -146.56 -131.34 REMARK 500 ARG B 245 -51.67 79.45 REMARK 500 ARG B 274 -3.37 68.35 REMARK 500 ASP B 293 94.09 62.13 REMARK 500 ASP B 303 -116.38 21.83 REMARK 500 ASN B 325 -156.02 67.46 REMARK 500 LEU B 385 32.15 -96.02 REMARK 500 ASP B 399 -112.37 55.15 REMARK 500 GLN B 429 48.46 -89.12 REMARK 500 GLN B 472 55.47 -144.37 REMARK 500 PHE B 473 -146.44 -131.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G96 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G96 B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3E87 RELATED DB: PDB REMARK 900 RELATED ID: 3E8C RELATED DB: PDB REMARK 900 RELATED ID: 3E8D RELATED DB: PDB REMARK 900 RELATED ID: 3E8E RELATED DB: PDB DBREF 3E88 A 146 480 UNP P31751 AKT2_HUMAN 146 480 DBREF 3E88 B 146 480 UNP P31751 AKT2_HUMAN 146 480 DBREF 3E88 C 3 12 UNP P49841 GSK3B_HUMAN 3 12 DBREF 3E88 D 3 12 UNP P49841 GSK3B_HUMAN 3 12 SEQADV 3E88 ASP A 474 UNP P31751 SER 474 ENGINEERED MUTATION SEQADV 3E88 ASP B 474 UNP P31751 SER 474 ENGINEERED MUTATION SEQRES 1 A 335 LYS VAL THR MET ASN ASP PHE ASP TYR LEU LYS LEU LEU SEQRES 2 A 335 GLY LYS GLY THR PHE GLY LYS VAL ILE LEU VAL ARG GLU SEQRES 3 A 335 LYS ALA THR GLY ARG TYR TYR ALA MET LYS ILE LEU ARG SEQRES 4 A 335 LYS GLU VAL ILE ILE ALA LYS ASP GLU VAL ALA HIS THR SEQRES 5 A 335 VAL THR GLU SER ARG VAL LEU GLN ASN THR ARG HIS PRO SEQRES 6 A 335 PHE LEU THR ALA LEU LYS TYR ALA PHE GLN THR HIS ASP SEQRES 7 A 335 ARG LEU CYS PHE VAL MET GLU TYR ALA ASN GLY GLY GLU SEQRES 8 A 335 LEU PHE PHE HIS LEU SER ARG GLU ARG VAL PHE THR GLU SEQRES 9 A 335 GLU ARG ALA ARG PHE TYR GLY ALA GLU ILE VAL SER ALA SEQRES 10 A 335 LEU GLU TYR LEU HIS SER ARG ASP VAL VAL TYR ARG ASP SEQRES 11 A 335 ILE LYS LEU GLU ASN LEU MET LEU ASP LYS ASP GLY HIS SEQRES 12 A 335 ILE LYS ILE THR ASP PHE GLY LEU CYS LYS GLU GLY ILE SEQRES 13 A 335 SER ASP GLY ALA THR MET LYS TPO PHE CYS GLY THR PRO SEQRES 14 A 335 GLU TYR LEU ALA PRO GLU VAL LEU GLU ASP ASN ASP TYR SEQRES 15 A 335 GLY ARG ALA VAL ASP TRP TRP GLY LEU GLY VAL VAL MET SEQRES 16 A 335 TYR GLU MET MET CYS GLY ARG LEU PRO PHE TYR ASN GLN SEQRES 17 A 335 ASP HIS GLU ARG LEU PHE GLU LEU ILE LEU MET GLU GLU SEQRES 18 A 335 ILE ARG PHE PRO ARG THR LEU SER PRO GLU ALA LYS SER SEQRES 19 A 335 LEU LEU ALA GLY LEU LEU LYS LYS ASP PRO LYS GLN ARG SEQRES 20 A 335 LEU GLY GLY GLY PRO SER ASP ALA LYS GLU VAL MET GLU SEQRES 21 A 335 HIS ARG PHE PHE LEU SER ILE ASN TRP GLN ASP VAL VAL SEQRES 22 A 335 GLN LYS LYS LEU LEU PRO PRO PHE LYS PRO GLN VAL THR SEQRES 23 A 335 SER GLU VAL ASP THR ARG TYR PHE ASP ASP GLU PHE THR SEQRES 24 A 335 ALA GLN SER ILE THR ILE TPO PRO PRO ASP ARG TYR ASP SEQRES 25 A 335 SER LEU GLY LEU LEU GLU LEU ASP GLN ARG THR HIS PHE SEQRES 26 A 335 PRO GLN PHE ASP TYR SER ALA SER ILE ARG SEQRES 1 B 335 LYS VAL THR MET ASN ASP PHE ASP TYR LEU LYS LEU LEU SEQRES 2 B 335 GLY LYS GLY THR PHE GLY LYS VAL ILE LEU VAL ARG GLU SEQRES 3 B 335 LYS ALA THR GLY ARG TYR TYR ALA MET LYS ILE LEU ARG SEQRES 4 B 335 LYS GLU VAL ILE ILE ALA LYS ASP GLU VAL ALA HIS THR SEQRES 5 B 335 VAL THR GLU SER ARG VAL LEU GLN ASN THR ARG HIS PRO SEQRES 6 B 335 PHE LEU THR ALA LEU LYS TYR ALA PHE GLN THR HIS ASP SEQRES 7 B 335 ARG LEU CYS PHE VAL MET GLU TYR ALA ASN GLY GLY GLU SEQRES 8 B 335 LEU PHE PHE HIS LEU SER ARG GLU ARG VAL PHE THR GLU SEQRES 9 B 335 GLU ARG ALA ARG PHE TYR GLY ALA GLU ILE VAL SER ALA SEQRES 10 B 335 LEU GLU TYR LEU HIS SER ARG ASP VAL VAL TYR ARG ASP SEQRES 11 B 335 ILE LYS LEU GLU ASN LEU MET LEU ASP LYS ASP GLY HIS SEQRES 12 B 335 ILE LYS ILE THR ASP PHE GLY LEU CYS LYS GLU GLY ILE SEQRES 13 B 335 SER ASP GLY ALA THR MET LYS TPO PHE CYS GLY THR PRO SEQRES 14 B 335 GLU TYR LEU ALA PRO GLU VAL LEU GLU ASP ASN ASP TYR SEQRES 15 B 335 GLY ARG ALA VAL ASP TRP TRP GLY LEU GLY VAL VAL MET SEQRES 16 B 335 TYR GLU MET MET CYS GLY ARG LEU PRO PHE TYR ASN GLN SEQRES 17 B 335 ASP HIS GLU ARG LEU PHE GLU LEU ILE LEU MET GLU GLU SEQRES 18 B 335 ILE ARG PHE PRO ARG THR LEU SER PRO GLU ALA LYS SER SEQRES 19 B 335 LEU LEU ALA GLY LEU LEU LYS LYS ASP PRO LYS GLN ARG SEQRES 20 B 335 LEU GLY GLY GLY PRO SER ASP ALA LYS GLU VAL MET GLU SEQRES 21 B 335 HIS ARG PHE PHE LEU SER ILE ASN TRP GLN ASP VAL VAL SEQRES 22 B 335 GLN LYS LYS LEU LEU PRO PRO PHE LYS PRO GLN VAL THR SEQRES 23 B 335 SER GLU VAL ASP THR ARG TYR PHE ASP ASP GLU PHE THR SEQRES 24 B 335 ALA GLN SER ILE THR ILE TPO PRO PRO ASP ARG TYR ASP SEQRES 25 B 335 SER LEU GLY LEU LEU GLU LEU ASP GLN ARG THR HIS PHE SEQRES 26 B 335 PRO GLN PHE ASP TYR SER ALA SER ILE ARG SEQRES 1 C 10 GLY ARG PRO ARG THR THR SER PHE ALA GLU SEQRES 1 D 10 GLY ARG PRO ARG THR THR SER PHE ALA GLU MODRES 3E88 TPO A 309 THR PHOSPHOTHREONINE MODRES 3E88 TPO A 451 THR PHOSPHOTHREONINE MODRES 3E88 TPO B 309 THR PHOSPHOTHREONINE MODRES 3E88 TPO B 451 THR PHOSPHOTHREONINE HET TPO A 309 11 HET TPO A 451 11 HET TPO B 309 11 HET TPO B 451 11 HET G96 A 1 34 HET G96 B 1 34 HETNAM TPO PHOSPHOTHREONINE HETNAM G96 4-[2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-6-{[(2R)-2-AMINO-3- HETNAM 2 G96 PHENYLPROPYL]OXY}-1-ETHYL-1H-IMIDAZO[4,5-C]PYRIDIN-4- HETNAM 3 G96 YL]-2-METHYLBUT-3-YN-2-OL HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 4(C4 H10 N O6 P) FORMUL 5 G96 2(C24 H27 N7 O3) FORMUL 7 HOH *62(H2 O) HELIX 1 1 THR A 148 ASN A 150 5 3 HELIX 2 2 LYS A 185 LYS A 191 1 7 HELIX 3 3 GLU A 193 THR A 207 1 15 HELIX 4 4 LEU A 237 ARG A 245 1 9 HELIX 5 5 THR A 248 ARG A 269 1 22 HELIX 6 6 THR A 313 LEU A 317 5 5 HELIX 7 7 ALA A 318 GLU A 323 5 6 HELIX 8 8 ALA A 330 GLY A 346 1 17 HELIX 9 9 ASP A 354 GLU A 365 1 12 HELIX 10 10 SER A 374 LEU A 385 1 12 HELIX 11 11 ASP A 399 GLU A 405 1 7 HELIX 12 12 HIS A 406 LEU A 410 5 5 HELIX 13 13 ASN A 413 GLN A 419 1 7 HELIX 14 14 ASP A 440 ALA A 445 1 6 HELIX 15 15 THR B 148 ASN B 150 5 3 HELIX 16 16 LYS B 185 LYS B 191 1 7 HELIX 17 17 GLU B 193 THR B 207 1 15 HELIX 18 18 LEU B 237 ARG B 245 1 9 HELIX 19 19 THR B 248 ARG B 269 1 22 HELIX 20 20 THR B 313 LEU B 317 5 5 HELIX 21 21 ALA B 318 GLU B 323 5 6 HELIX 22 22 ALA B 330 GLY B 346 1 17 HELIX 23 23 ASP B 354 GLU B 365 1 12 HELIX 24 24 SER B 374 LEU B 385 1 12 HELIX 25 25 ASP B 399 GLU B 405 1 7 HELIX 26 26 HIS B 406 LEU B 410 5 5 HELIX 27 27 ASN B 413 GLN B 419 1 7 HELIX 28 28 ASP B 440 ALA B 445 1 6 SHEET 1 A 6 PHE A 152 LYS A 160 0 SHEET 2 A 6 GLY A 164 GLU A 171 -1 O VAL A 166 N GLY A 159 SHEET 3 A 6 TYR A 177 ARG A 184 -1 O ILE A 182 N LYS A 165 SHEET 4 A 6 ARG A 224 GLU A 230 -1 O MET A 229 N ALA A 179 SHEET 5 A 6 LEU A 215 GLN A 220 -1 N PHE A 219 O CYS A 226 SHEET 6 A 6 TYR A 475 SER A 476 -1 O TYR A 475 N ALA A 218 SHEET 1 B 3 GLY A 235 GLU A 236 0 SHEET 2 B 3 LEU A 281 LEU A 283 -1 O LEU A 283 N GLY A 235 SHEET 3 B 3 ILE A 289 ILE A 291 -1 O LYS A 290 N MET A 282 SHEET 1 C 2 VAL A 271 VAL A 272 0 SHEET 2 C 2 LYS A 298 GLU A 299 -1 O LYS A 298 N VAL A 272 SHEET 1 D 2 CYS A 311 GLY A 312 0 SHEET 2 D 2 PHE C 10 ALA C 11 -1 O PHE C 10 N GLY A 312 SHEET 1 E 6 PHE B 152 LYS B 160 0 SHEET 2 E 6 GLY B 164 GLU B 171 -1 O VAL B 166 N GLY B 159 SHEET 3 E 6 TYR B 177 ARG B 184 -1 O ILE B 182 N LYS B 165 SHEET 4 E 6 ARG B 224 GLU B 230 -1 O MET B 229 N ALA B 179 SHEET 5 E 6 LEU B 215 GLN B 220 -1 N PHE B 219 O CYS B 226 SHEET 6 E 6 TYR B 475 SER B 476 -1 O TYR B 475 N ALA B 218 SHEET 1 F 3 GLY B 235 GLU B 236 0 SHEET 2 F 3 LEU B 281 LEU B 283 -1 O LEU B 283 N GLY B 235 SHEET 3 F 3 ILE B 289 ILE B 291 -1 O LYS B 290 N MET B 282 SHEET 1 G 2 VAL B 271 VAL B 272 0 SHEET 2 G 2 LYS B 298 GLU B 299 -1 O LYS B 298 N VAL B 272 SHEET 1 H 2 CYS B 311 GLY B 312 0 SHEET 2 H 2 PHE D 10 ALA D 11 -1 O PHE D 10 N GLY B 312 LINK C LYS A 308 N TPO A 309 1555 1555 1.33 LINK C TPO A 309 N PHE A 310 1555 1555 1.33 LINK C ILE A 450 N TPO A 451 1555 1555 1.33 LINK C LYS B 308 N TPO B 309 1555 1555 1.33 LINK C TPO B 309 N PHE B 310 1555 1555 1.33 LINK C ILE B 450 N TPO B 451 1555 1555 1.33 SITE 1 AC1 19 GLY A 159 GLY A 161 GLY A 164 LYS A 165 SITE 2 AC1 19 VAL A 166 ALA A 179 LYS A 181 LEU A 183 SITE 3 AC1 19 GLU A 200 PHE A 227 MET A 229 GLU A 230 SITE 4 AC1 19 TYR A 231 ALA A 232 MET A 282 THR A 292 SITE 5 AC1 19 ASP A 293 PHE A 294 PHE A 439 SITE 1 AC2 18 GLY B 159 GLY B 164 LYS B 165 VAL B 166 SITE 2 AC2 18 ALA B 179 LYS B 181 LEU B 183 GLU B 200 SITE 3 AC2 18 MET B 229 GLU B 230 TYR B 231 ALA B 232 SITE 4 AC2 18 MET B 282 THR B 292 ASP B 293 PHE B 294 SITE 5 AC2 18 PHE B 439 SER D 9 CRYST1 116.885 116.885 45.115 90.00 90.00 120.00 P 32 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008555 0.004939 0.000000 0.00000 SCALE2 0.000000 0.009879 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022166 0.00000